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Introduction
Rheumatic diseases in adults are associated with
increased incidence of cardiovascular disease. Compared
to many publications related to the risk of atherosclerosis
and its complications in patients with rheumatoid arthritis,
only few observations have been published on the subject
of patients with idiopathic juvenile arthritis (JIA).
Objectives
The aim of the study was assessing the early vascular
disorders associated with atherosclerosis in children
with juvenile idiopathic arthritis based on analysis of
biomarkers of subclinical atherosclerosis. As biomarkers
associated with early atherosclerosis adiponectin and
leptin were selected. Because of the possible association
between the evaluated biomarkers and inflammation
process of joints, the study was conducted in patients
during treatment, but in period without disease activity, in
order to eliminate the direct impact of arthritis on the test
results. Influence of the onset type, duration of the disease
and the treatment on evaluated biomarkers and their asso-
ciation with factors connected with cardiovascular risk
such as lipid levels and BMI percentile were analyzed.
Methods
The study was performed in 56 children with JIA, 4-16
years old, without disease activity, during therapy with
at least one disease modifying drug, with or without
glucocorticoid (at a dose of ≤ 10 mg/day or ≤ 0.2 mg/kg
body weight) and 19 healthy children as a control
group. 25 patients had oligoarticular onset of disease,
21 - polyarticular onset, 8 had enthesitis-related arthritis
and 2 had systemic onset of JIA.
Analysis of blood count, ESR, CRP, cholesterol, trigly-
cerides, LDL and HDL cholesterol and artherosclerosis
biomarkers were assessed in all examined children. The
concentrations of leptin, adiponectin were made by
enzyme immunoassay method using the kits for the
quantitative tests in blood serum.
Results
There were no significant differences between the con-
centrations in the blood adiponectin, leptin in patients
with JIA and control groups. There were no also differ-
ences in the parameters between patients with different
forms of the disease.
The parameters in the early period JIA (≤ 1 year) and
later (> 1 year) were not differenced significant. In the
group of children with JIA, a positive correlation
between leptin levels and duration of the disease was
found. There were no differences in the parameters
between the groups of patients treated and not treated
with methotrexate, etanercept or glucocorticoids. There
were no negative effects of therapy with glucocorticoids
and methotrexate on assessed biomarkers. Serum leptin
concentrations in the whole study group were signifi-
cantly higher in girls than in boys. There was a positive
correlation between serum leptin and parameters of
nutritional status.
Conclusion
The lack of differences between the biomarkers of early
atherosclerosis in group of JIA patients compared to the
control group, indicates a reduced risk of cardiovascular
diseases, in terms of effective therapy.1Dept. of Paediatric Pulmonology and Rheumatology, Medical University of
Lublin, Poland
Full list of author information is available at the end of the article
Opoka-Winiarska et al. Pediatric Rheumatology 2013, 11(Suppl 2):P126
http://www.ped-rheum.com/content/11/S2/P126
© 2013 Opoka-Winiarska et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
The type of treatment do not have impact on the bio-
markers, which means that did not increase the risk of
vascular disease, the treatment efficacy is more important
than the type of used drug. The subtype of the disease
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